Article info
PDFInflammatory bowel disease
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
- Correspondence to:
Dr J D Lewis
University of Pennsylvania, 720 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021, USA; jlewiscceb.med.upenn.edu
Citation
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
Publication history
- Accepted January 4, 2005
- Revised December 22, 2004
- First published July 11, 2005.
Online issue publication
July 11, 2005
Competing interest: JDL has received research support and has served as a consultant for Wyeth and GlaxoSmithKline. BIK has received research funding from Centocor. AK, AGF, and CB report no potential conflicts of interest.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by Gut